Phase 1 Technology Commercialization Grant: Allosteric modulators of μ-opioid and cannabinoid CB1 receptors as potential therapeutics
Phase 1 Technology Commercialization Grant: Allosteric modulators of μ-opioid and cannabinoid CB1 receptors as potential therapeutics